These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 3236762)
1. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762 [TBL] [Abstract][Full Text] [Related]
2. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns. Schulman SL; Kaiser BA; Polinsky MS; Srinivasan R; Baluarte HJ J Pediatr; 1988 Dec; 113(6):996-1001. PubMed ID: 3193322 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR). Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687 [TBL] [Abstract][Full Text] [Related]
4. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology. Meyrier A; Condamin MC; Broneer D Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266 [TBL] [Abstract][Full Text] [Related]
5. Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis. Ponticelli C; Rivolta E Am J Nephrol; 1990; 10 Suppl 1():105-9. PubMed ID: 2256469 [TBL] [Abstract][Full Text] [Related]
6. Late resistance to corticosteroids in nephrotic syndrome. Srivastava RN; Agarwal RK; Moudgil A; Bhuyan UN J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis. Windom HH; Fisher M; Neale TJ N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A in the treatment of childhood glomerulonephritis. James RW; Burke JR; Petrie JJ; Rigby RJ; Williams M Aust N Z J Med; 1989 Jun; 19(3):198-201. PubMed ID: 2775040 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543 [TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome. Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses. Chan MK; Cheng IK Postgrad Med J; 1987 Sep; 63(743):757-9. PubMed ID: 3444800 [TBL] [Abstract][Full Text] [Related]
12. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis]. Klinger M; Szewczyk Z Przegl Lek; 1989; 46(10):744-9. PubMed ID: 2687950 [No Abstract] [Full Text] [Related]
13. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions. Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C Nephron; 1985; 41(2):170-3. PubMed ID: 4047274 [TBL] [Abstract][Full Text] [Related]
16. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265 [TBL] [Abstract][Full Text] [Related]
17. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie. Meyrier A; Noël LH; Auriche P; Callard P Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of heavy proteinuria in patients under 2 years of age. Chang JW; Lin CY Pediatr Nephrol; 2003 Oct; 18(10):1044-8. PubMed ID: 12898378 [TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study. Clasen W; Kindler J; Mihatsch MJ; Sieberth HG Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414 [TBL] [Abstract][Full Text] [Related]
20. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. Gregory MJ; Smoyer WE; Sedman A; Kershaw DB; Valentini RP; Johnson K; Bunchman TE J Am Soc Nephrol; 1996 Apr; 7(4):543-9. PubMed ID: 8724887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]